Almirall and Quintiles, Inc. (QTRN) Sign Long-Term Commercial UK Partnership  
7/30/2012 9:37:21 AM

LONDON & READING, United Kingdom--(BUSINESS WIRE)--Almirall and Quintiles have reached a long-term strategic partnership agreement to promote Almirall’s respiratory portfolio in the UK commencing with a new, long-acting antimuscarinic (LAMA) delivered via an innovative, multi-dose inhaler for the treatment of chronic obstructive pulmonary disease (COPD).